Transmyocardial laser revascularization: surgical experience overview

Transmyocardial revascularization (TMR) using holmium:yttrium-aluminium-garnet (YAG) and carbon dioxide lasers has been approved by the United States Food and Drug Administration for the treatment of medically refractory angina in patients without conventional options. In prospective, randomized tri...

Full description

Saved in:
Bibliographic Details
Published inSeminars in interventional cardiology : SIIC Vol. 5; no. 2; p. 75
Main Authors Allen, K B, Shaar, C J
Format Journal Article
LanguageEnglish
Published England 01.06.2000
Subjects
Angina Pectoris - surgery
Carbon Dioxide
Coronary Artery Bypass
Coronary Circulation
Exercise Tolerance
Humans
Laser Therapy - instrumentation
Myocardial Revascularization - instrumentation
Myocardial Revascularization - methods
Randomized Controlled Trials as Topic
Online AccessGet more information

Cover

More Information
Summary:Transmyocardial revascularization (TMR) using holmium:yttrium-aluminium-garnet (YAG) and carbon dioxide lasers has been approved by the United States Food and Drug Administration for the treatment of medically refractory angina in patients without conventional options. In prospective, randomized trials, patients who received TMR experienced improved angina, better-event free survival, and reduction in cardiac-related rehospitalizations when compared to patients remaining on medical therapy alone. In addition, TMR as an adjunct to coronary artery bypass grafting (CABG) has resulted in improved clinical status for patients who would not be completely revascularized by CABG alone.
ISSN:1084-2764